Search results for "Eosin"

showing 10 items of 275 documents

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.

2020

Background: Current availability of several biologic treatments for severe asthma makes it possible to choose the most appropriate for each patient. Sometimes a good percentage of patients with severe asthma may be eligible for biologics that target either the allergic phenotype or the eosinophilic one, but not all respond to that selected as first choice. The aim of our real-life study was to assess whether, for patients with severe eosinophilic allergic asthma, not previously controlled by the anti-IgE omalizumab, the shift to another biologic targeting interleukin-5, such as mepolizumab, may represent a good therapeutic choice. Methods: A total of 41 consecutive patients with severe, per…

AdultMale0301 basic medicinePulmonary and Respiratory Medicinesevere asthmamedicine.medical_specialtyTime FactorsSevere asthmamepolizumab omalizumab severe asthma switchingOmalizumabSettore MED/10 - Malattie Dell'Apparato RespiratorioAntibodies Monoclonal HumanizedSeverity of Illness Index03 medical and health sciences0302 clinical medicinereal lifeAnti-Allergic AgentsHumansMedicineswitching.Pharmacology (medical)Anti-Asthmatic AgentsPulmonary EosinophiliaIntensive care medicineLungOriginal ResearchAgedRetrospective Studieslcsh:RC705-779switchingDrug Substitutionbusiness.industrymepolizumablcsh:Diseases of the respiratory systemMiddle AgedAsthmaTreatment Outcome030104 developmental biologyItaly030228 respiratory systemomalizumabFemalebusinessMepolizumabmedicine.drug
researchProduct

Clinical course of rhinitis and changes in vivo and in vitro of allergic parameters in elderly patients: a long-term follow-up study

2012

Changes in rhinitis symptom severity tend to decrease with aging, but whether the decrease is associated with allergic skin test reactivity, serum total and specific IgE, and nasal eosinophils or determined only by aging is poorly understood. The aim of the study was to analyze sensitivity in vivo and in vitro some 15 years after primary testing, skin prick test (SPT), serum total and specific IgE, ratio sIgE/tIgE, and nasal eosinophils in order to evaluate changes due to age and changes due to the severity of rhinitis symptoms. One hundred and eight rhinitis patients who had been investigated in 1995 were re-interviewed and their current allergy re-assessed after a follow-up of 15 years. A…

AdultMaleAgingmedicine.medical_specialtyAllergySettore MED/09 - Medicina InternaRhinitis Allergic PerennialMucous membrane of noseImmunoglobulin ESeverity of Illness IndexGeneral Biochemistry Genetics and Molecular BiologySerum total IgEIn vivoInternal medicineSeverity of illnessAllergic rhinitimedicineHumansAgedSkinHematologybiologybusiness.industrySerum-specific IgEAge FactorsClinical courseGeneral MedicineImmunoglobulin EMiddle Agedmedicine.diseaseRhinitis AllergicSymptom scoreIn vitroEosinophil in nasal fluidEosinophilsNasal MucosaItalyImmunologybiology.proteinFemalebusinessFollow-Up StudiesClinical and Experimental Medicine
researchProduct

Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis.

2001

Eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EPX) are cytotoxic molecules involved in helminth infections and allergic reactions. Hitherto most clinical chemical studies have been concerned with the analysis of serum ECP in allergic diseases. The aim of this study was to examine whether serum as well as urine levels of these proteins are useful clinical chemical parameters in helminthiases and allergic diseases such as atopic dermatitis. Comparing these diseases under the same methodological conditions, levels of ECP and EPX were generally higher in helminthiases than in atopic dermatitis and non-helminth, non-allergic diseases. The highest levels of both proteins oc…

AdultMaleAllergyAdolescentHelminthiasisHelminthiasisEosinophil-derived neurotoxinSchistosomiasisEosinophil-Derived NeurotoxinBiologyDermatitis AtopicAtopyRibonucleasesPredictive Value of Testsparasitic diseasesmedicineEosinophiliaHumansEosinophil cationic proteinPublic Health Environmental and Occupational HealthProteinsAtopic dermatitisBlood ProteinsEosinophil Granule ProteinsMiddle Agedmedicine.diseaseInfectious DiseasesCase-Control StudiesImmunologyParasitologyFemalemedicine.symptomTropical medicineinternational health : TMIH
researchProduct

The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secre…

1999

Activation of mast cells and eosinophils under pollen exposure can be inhibited by specific immunotherapy.The effect of short-term immunotherapy with 7 preseasonal injections of molecular standardized allergens from grass and rye pollen on eosinophil cationic protein (ECP) and tryptase levels in nasal secretions has been compared with symptomatic drug treatment in an open, randomized study with 48 patients.Nasal reactivity and mediator levels in nasal secretions were measured at baseline, before season, in season, and after season.Symptom scores in the immunotherapy group were 134.5 (95% CI, 65 to 336) versus 386. 0 (95% CI, 185 to 563), significantly lower as in the drug-treated group. ECP…

AdultMaleAllergyRhinitis Allergic PerennialTime FactorsAdolescentmedicine.medical_treatmentImmunologyTryptasemedicine.disease_causeNasal provocation testAllergenChymasesRibonucleasesmedicineImmunology and AllergyHumansEosinophil cationic proteinbiologybusiness.industrySerine EndopeptidasesAeroallergenImmunotherapyBlood ProteinsAllergensEosinophil Granule ProteinsMiddle AgedMast cellmedicine.diseaseNasal Mucosamedicine.anatomical_structureImmunologybiology.proteinFemaleTryptasesImmunotherapyInflammation MediatorsbusinessThe Journal of allergy and clinical immunology
researchProduct

Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.

2009

Background: To date, no predictive tests for the clinical response to allergen-specific immunotherapy (ASI) are available. Therefore an in vivo or in vitro test would be of great value. Objective: We sought to evaluate pretreatment parameters used in diagnosing allergic rhinitis and determining serum specific IgE (s-IgE) levels, serum total IgE (t-IgE) levels, and blood eosinophil counts and to identify whether can be used to predict clinical improvement in monosensitized patients with allergic rhinitis with or without asthma treated with immunotherapy. Methods:We analyzed 279 patients who had undergone 4 years of ASI administered either by means of the subcutaneous immunotherapy (76 patien…

AdultMaleAllergySettore MED/09 - Medicina InternaRhinitis Allergic PerennialAdolescentmedicine.medical_treatmentImmunologyspecific IgEImmunoglobulin Eblood eosinophil countsYoung AdultBlood serummedicineImmunology and AllergyHumansreceiver operating characteristic curveAsthmaDesensitization (medicine)Retrospective StudiesSkin Testsserum s-IgE/total IgE ratio; allergen-specific immunotherapyHouse dust miteserum s-IgE/total IgE ratiobiologyserum-specific IgE/serum total IgE ratiobusiness.industryAllergen-specific immunotherapy; blood eosinophil counts; receiver operating characteristic curve; serum-specific IgE/serum total IgE ratio; specific IgE; total IgEArea under the curveImmunotherapyAllergensImmunoglobulin EMiddle Agedmedicine.diseasebiology.organism_classificationPrognosisAllergen-specific immunotherapyBlood Cell Counttotal IgEEosinophilsTreatment OutcomeDesensitization ImmunologicSpirometryImmunologybiology.proteinFemalebusiness
researchProduct

Variant Three-Way Translocation of Inversion 16 in AML-M4Eo Confirmed by Fluorescence In Situ Hybridization Analysis

1999

The inv(16) and t(16;16) characterize a subgroup of acute myelomonocytic leukemia (AML) with distinct morphological features and a favorable prognosis. Both cytogenetic abnormalities result in a fusion of CBF beta at 16q22 and MYH11 gene at 16p13, whose detection by PCR and fluorescence in situ hybridization (FISH) is useful for diagnosis and monitoring of the disease. Variant translocations of inv(16)/t(16;16) are very rare and whether they are also associated with a favorable prognosis is unknown. We report a patient presenting with typical AML-M4Eo and a three-way translocation of inv(16) involving 16p13, 16q22, and 3q22. FISH studies on bone marrow (BM) chromosomes using CBFB and MYH11 …

AdultMaleCancer ResearchChromosomal translocationBiologyLeukemia Myelomonocytic AcuteTranslocation GeneticChromosome 16GeneticsmedicineHumansMolecular BiologyIn Situ Hybridization FluorescenceChromosomal inversionmedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionHybridization probemedicine.diseaseMolecular biologyEosinophilsLeukemiaFusion transcriptChromosome InversionAcute myelomonocytic leukemiaFemaleChromosomes Human Pair 16Fluorescence in situ hybridizationCancer Genetics and Cytogenetics
researchProduct

A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours.

2012

Abstract Background EMD 521873 (Selectikine), an immunocytokine comprising a DNA-targeting antibody, aimed at tumour necrosis, fused with a genetically modified interleukin-2 (IL-2) moiety, was investigated in this first-in-human phase I study. Methods Patients had metastatic or locally advanced solid tumours failing previous standard therapy. Selectikine was administered as a 1-hour intravenous infusion on 3 consecutive days, every 3weeks. A subgroup of patients also received 300mg/m 2 cyclophosphamide on day 1 of each cycle. Escalating doses of Selectikine were investigated with the primary objective of determining the maximum tolerated dose (MTD). Results Thirty-nine patients were treate…

AdultMaleCancer Researchmedicine.medical_specialtyNecrosisCyclophosphamideMaximum Tolerated DoseLymphocyteRecombinant Fusion ProteinsSelectikineAntineoplastic AgentsPharmacologyGastroenterologyEMD 521873Young AdultPhase IDose-escalationInternal medicineNeoplasmsmedicineHumansAgedbiologyDose-Response Relationship Drugbusiness.industryEosinophilMiddle AgedRashAdvanced solid tumoursmedicine.anatomical_structureOncologyToxicitybiology.proteinInterleukin-2SelectikineFemalemedicine.symptomAntibodybusinessmedicine.drugEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Uncommon clinical presentation of Kimura’s disease as bilateral retroauricular masses in a young Malian male: successful surgical approach.

2016

We present a case of a 27 year-old Malian male referred to our hospital for two large, painless retroauricolar masses that had appeared two years earlier. Bilateral cervical painless lymphadenopathy was present at physical examination, without any other systemic symptoms. His history was relevant for bilateral Kimura’s disease lesions resected 5 years earlier in the same locations. Lymphocytosis and a mild hypereosinophilia were found in routine blood tests, together with increased total IgE levels. After surgery, histology showed lymphoid infiltrates with reactive prominent germinal centres containing eosinophils, suggesting relapse of Kimura’s disease, in the context of nonencapsulated fi…

AdultMaleKimura diseaseCancer ResearchPhysiologyEndocrinology Diabetes and MetabolismImmunologyAngiolymphoid Hyperplasia with EosinophiliaNon-AsianFibrosisKeloid Kimura disease neck retroauricolar non-AsianTreatment OutcomeEndocrinologyOncologyRecurrenceKeloidPhysiology (medical)retroauricolarHumansImmunology and AllergyRetroauricularNeck
researchProduct

Spectrum of histopathologic findings in patients with achalasia reflects different etiologies

2006

Background:  The etiology of achalasia is still unknown. The aim of the present study was to illucidate its underlying pathologies and their chronology by investigation of esophageal specimens in patients undergoing surgery (esophageal resection or myotomy) for achalasia. Methods:  In 17 patients with achalasia, histopathologic examinations of the esophageal wall focussing on the myenteric plexus were performed. Preoperative diagnosis was based on clinical evaluation, esophagogastroscopy, barium esophagogram in all, and esophageal manometry in eight patients. The median age at the time of surgery was 54 years (range: 14–78 years). In eight cases, the complete esophageal, body and in nine ca…

AdultMaleMyotomyPathologymedicine.medical_specialtyAdolescentmedicine.medical_treatmentMyocytes Smooth MuscleH&E stainAchalasiaEsophagusEosinophilicBiopsymedicineCarcinomaHumansEsophagusMyopathyAgedHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyMiddle Agedmedicine.diseaseEsophageal Achalasiamedicine.anatomical_structureFemalemedicine.symptombusinessJournal of Gastroenterology and Hepatology
researchProduct

Differences and Similarities between Allergic and Nonallergic Rhinitis in a Large Sample of Adult Patients with Rhinitis Symptoms

2010

<i>Background:</i> Allergic rhinitis (AR) and nonallergic rhinitis (NAR) may present with different clinical and laboratory characteristics. <i>Methods:</i> A total of 1,511 consecutive patients, aged 18–81 years, diagnosed with rhinitis, 56% females and 44% males, underwent complete allergic evaluation including skin prick test, blood eosinophil counts, nasal eosinophil counts, peak nasal inspiratory flow (PNIF) measurement and evaluation of nasal symptoms using a visual analog scale (VAS). <i>Results:</i> A total of 1,107 patients (73%)had AR, whereas 404 (27%) had NAR. Patients with NAR were older and predominantly female. A higher nasal eosinophils co…

AdultMaleNasal eosinophilAgingAllergyRhinitis Allergic PerennialSkin prick testPeak nasal inspiratory flowAdolescentNon allergic rhinitisVisual analogue scaleNon-allergic rhinitisImmunologyHistamine AntagonistsReceiver operating characteristicSettore MED/42 - Igiene Generale E ApplicataSeverity of Illness IndexAllergic rhinitisYoung AdultSex FactorsNonallergic rhinitisBlood eosinophilAllergic rhinitis; Non allergic rhinitis; Skin prick test; Peak nasal inspiratory flow; Blood eosinophil; Nasal eosinophil; Visual analog scale; Receiver operating characteristicHumansImmunology and AllergyMedicineAllergic rhinitis Non allergic rhinitis Skin prick test Peak nasal inspiratory flow Blood eosinophil Nasal eosinophil Visual analog scale Receiver operating characteristicVisual analog scaleYoung adultAgedRhinitisSkin TestsAged 80 and overAdult patientsbusiness.industryHeadacheGeneral MedicineMiddle AgedEosinophilConjunctivitismedicine.diseaseLarge sampleEosinophilsmedicine.anatomical_structureSettore MED/31 - OtorinolaringoiatriaImmunologyFemaleNasal Obstructionbusiness
researchProduct